Loading chat...

GA HB830

Bill

Official Source

Status

Passed

5/3/2018

Primary Sponsor

Buddy Harden

Click for details

Origin

House of Representatives

2017-2018 Regular Session

AI Summary

  • Adds fluorophenmetrazine to the list of Schedule I controlled substances and expands Schedule I definitions to cover additional synthetic drug structural variations, including alkoxy substitutions and cyclic alkyl groups
  • Adds dronabinol in oral solution (labeled per FDA requirements) to the Schedule II controlled substances list
  • Designates approximately 47 new pharmaceutical substances as "dangerous drugs" under Georgia law, including drugs such as abaloparatide, abemaciclib, semaglutide, dupilumab, and durvalumab
  • Creates an exception for levocetirizine at low doses (2.5 mg per 5 ml or less, or 5 mg or less per single dose unit) and raises the lidocaine topical threshold from 25 mg/gm ointment to 40 mg/gm (4%) or less
  • Becomes effective upon the Governor's approval or upon becoming law without such approval

Legislative Description

Controlled substances; Schedule I and II; change certain provisions

Last Action

Effective Date

5/3/2018

Full Bill Text

No bill text available